| AngioDynamics designs, manufactures and sells a range of medical, surgical and diagnostic devices used by healthcare providers. Co.'s product offerings fall within three Global Business Units: Endovascular Therapies, which supports the medical areas of thrombus management, Atherectomy, peripheral products and venous insufficiency; Oncology/Surgery, which provides a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation technology; and Vascular Access, which includes a range of peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters and related accessories and supplies. We show 48 historical shares outstanding datapoints in our ANGO shares outstanding history coverage, used to compute ANGO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ANGO market cap history over the course of time is important for investors
interested in comparing ANGO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ANGO versus a peer is one thing; comparing
ANGO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ANGO can fluctuate over the course of history.
With this page we aim to empower investors researching ANGO by allowing them to research the ANGO market cap history.